MarkKennethPlanteMD

PubMed

• 2 citations
  Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results.
  Mihir M. Desai, Mo Bidair, Naeem Bhojani, Andrew Trainer, Andrew Arther, Eugene V. Kramolowsky, Leo Doumanian, Dean Elterman, Ronald P. Kaufman, James E. Lingeman, Amy...> ;Canadian Journal of Urology. 2020 Apr 1
• 6 citations
  Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.
  Peter J. Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark A. Sutton, Tev Aho, Eugene V. Kramolowsky, Andrew P. Thomas, Barrett E. Cowan, Ronald P. Kaufman, An...> ;Canadian Journal of Urology. 2020 Feb 1
• Aquablation for benign prostatic hyperplasia in large prostates (80–150 mL): 6-month results from the WATER II trial
  Mihir M. Desai, Mo Bidair, Kevin C. Zorn, Andrew Trainer, Andrew Arther, Eugene V. Kramolowsky, Leo Doumanian, Dean Elterman, Ronald P. Kaufman, James E. Lingeman, Amy...> ;BJUI. 2019 Aug 1
• 10 citations
  Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results
  Naeem Bhojani, Mohamed Bidair, Kevin C. Zorn, Andrew Trainer, Andrew Arther, Eugene V. Kramolowsky, Leo Doumanian, Dean Elterman, Ronald P. Kaufman, James E. Lingeman,...> ;Urology. 2019 Jul 1
• 8 citations
  Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained
  Peter J. Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark A. Sutton, Tev Aho, Eugene V. Kramolowsky, Andrew Thomas, Barrett E. Cowan, Ronald P. Kaufman, Andre...> ;Advances in Therapy. 2019 Apr 26
• 5 citations
  Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial.
  Mark K. Plante, Peter J. Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark A. Sutton, Tev Aho, Eugene V. Kramolowsky, Andrew Thomas, Barrett E. Cowan, Ronald P...> ;BJUI. 2019 Apr 1
• WATER II (80–150 mL) procedural outcomes
  Mihir M. Desai, Mo Bidair, Naeem Bhojani, Andrew Trainer, Andrew Arther, Eugene V. Kramolowsky, Leo Doumanian, Dean Elterman, Ronald P. Kaufman, James E. Lingeman, Amy...> ;BJUI. 2019 Jan 1
• 43 citations
  WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia
  Peter J. Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark A. Sutton, Tev Aho, Eugene V. Kramolowsky, Andrew Thomas, Barrett E. Cowan, Ronald P. Kaufman, Andre...> ;The Journal of Urology. 2018 May 1
• Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.
  Laura Donnelly, Kevan M. Sternberg, Takamaru Ashikaga, Mark K. Plante, Scott D. Perrapato> ;Journal of Community Health. 2018 Feb 1
• Creation of a Ureterocystostomy in a Transplanted Cadaveric Kidney with the Use of a Radiofrequency Guide Wire
  Theodore Cisu, Curtis H. Cleveland, Christopher S. Morris, Mark K. Plante> ;Urology case reports. 2018 Jan 1
• Urinary Retention in Surgical Patients.
  Urszula Kowalik, Mark K. Plante> ;Surgical Clinics of North America. 2016 Jun 1
• Intraprostatic ethanol diffusion: comparison of two injection methods using ex vivo human prostates
  Benjamin King, Travis Mann-Gow, Masatoshi Kida, Mark K. Plante, S D Perrapato, Peter Zvara> ;Prostate Cancer and Prostatic Diseases. 2015 May 26
• Rat animal model for preclinical testing of microparticle urethral bulking agents.
  Travis Mann-Gow, Jerry G. Blaivas, Benjamin King, Ahmed El-Ghannam, Christine Knabe, Michael K Lam, Masatoshi Kida, Cameron Sikavi, Mark K. Plante, Jan Krhut, Peter Zvara> ;International Journal of Urology. 2015 Apr 1
• John Kingsley Lattimer: urologist, ballistics expert, and historian.
  Sutchin R. Patel, Terry W. Hensle, Mark K. Plante, Anthony A. Caldamone> ;Urology. 2014 Aug 1
• Benign DiseaseSurgical BPHEditorial Comment
  Mark K. Plante> ;Urology. 2014 Mar 1
• Pediatric Resident Exposure to Urology: Identifying a Need
  Hagop Sarkissian, Sarah Hardy, Mark Plante, Gerald C. Mingin> ;The Journal of Urology. 2013 Oct 1
• 3 citations
  Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells
  Mark K. Plante, W T Arscott, J B Folsom, S W Tighe, Robert J. Dempsey, Umadevi V. Wesley> ;Prostate Cancer and Prostatic Diseases. 2013 Mar 1
• Comparison of intraprostatic ethanol diffusion using a microporous hollow fiber catheter versus a standard needle.
  Benjamin King, Mark K. Plante, Masatoshi Kida, Travis Mann-Gow, Rick M. Odland, Peter Zvara> ;The Journal of Urology. 2012 May 1
• Ambulatory and Office UrologyComment
  Mark K. Plante> ;Urology. 2011 Jul 1
• Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hype...
  Henry H. Woo, Peter Chin, Thomas McNicholas, Harcharan Gill, Mark K. Plante, Reginald C. Bruskewitz, Claus G. Roehrborn> ;BJUI. 2011 Jul 1
• Retroperitoneoscopic nephrectomy with a modified hand-assisted approach.
  John-Paul Capolicchio, Arash Saemi, Samuel Trotter, Mark K. Plante> ;Urology. 2011 Mar 1
• Injection therapy for prostatic disease: A renaissance concept.
  Arash M Saemi, Jeffrey B. Folsom, Mark K. Plante> ;Indian Journal of Urology. 2008 Jul 1
• 4 citations
  Injectables in the prostate.
  Arash M Saemi, Mark K. Plante> ;Current Opinion in Urology. 2008 Jan 1
• Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
  Plante, M. K., Marks, L. S., Anderson, R., Amling, C., Rukstalis, D., Badlani, G., Getlin, L., Vang, E.> ;The Journal of urology. 2007 Feb 14
• Diffusion properties of transurethral intraprostatic injection
  Mark K. Plante, Andrew L. Gross, Jeffrey B. Folsom, Peter Zvara> ;BJUI. 2004 Dec 1
• Join now to see all